Centerspace (NYSE:CSR) has drawn income investors for a familiar reason: a mid-single-digitDividend Yieldbacked by a portfolio of apartment communities across Midwestern and mountain-region markets. With the shares recently near $53, the distribution puts the trailing yield close to 5.8%.
Self-storage has been one of the more resilient corners of commercial real estate, and CubeSmart is among the sector's larger landlords. With its shares trading in the high $30s, the real estateInvestmenttrust offers aDividend Yieldabove 5%.
Sun Belt office landlord Cousins Properties has held on to a following among income investors even as the broader office sector has struggled, and a trailingDividend Yieldin the mid-4% range is a big reason why. The Atlanta-based real estateInvestmenttrust concentrates on newer, amenity-rich towers …
Dynagas LNG Partners has drawn the attention of yield-seeking investors thanks to a common-unit distribution that, against a low unit price, works out to a trailing yield in the mid-5% range. As a shipping partnership that owns liquefied-natural-gas carriers on multi-year charters, Dynagas offers …
Eastman Chemical Company is better known for specialty plastics, additives and fibers than for its dividend, but a payout that has risen for well over a decade has quietly turned it into an income name as well.
Carlsmed, Inc. (NASDAQ: CARL) appointed Jeffrey Bertolini chief operating officer effective September 8, 2026, increasing his annual salary to $475,000. TheLeadershipchange also raises his target annual cash incentive to 60% of base salary and includes a grant of 50,000 stock options.
Dyne Therapeutics, Inc. (NASDAQ: DYN) CEO and President John Cox sold 5,658 shares at $18.88 per share on Sep. 8, 2026. The transaction left Cox with 357,507 shares.
EnGene Therapeutics Inc. (NASDAQ: ENGN) recorded a quarterly net loss attributable to common shareholders of approximately $32.5 million, or $0.47 per share, for the period ended July 31, 2026. The results included clinical and corporate updates for detalimogene.
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) began trading on the Nasdaq Global Select Market on September 8, 2026, after moving from the Nasdaq Capital Market. Its Toronto Stock Exchange listing remains unchanged, and shareholders do not need to take action. Eupraxia’s common shares continue to …
The update was issued on September 8, 2026. GRI (NASDAQ: GRI)-0621 is identified in the materials as oral tazarotene, with the program described as positive across Phase 2 endpoints.